Patent pending: how Trump’s pharma tariff shakes global medicine | Commercial Awareness Compass #54

President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. 
The proposal raises difficult questions for both governments and lawyers. How would a policy like this reshape pharmaceutical trade? Which countries and companies would bear the greatest cost? And what does this mean for innovation, intellectual property and access to medicines worldwide? 

The Commercial Awareness Compass by AllAboutLaw, helps you build your commercial awareness every week with a beginners, intermediate and advanced breakdown of a story from an expert lawyer and trainee solicitor host.

This story was taken from a live conversation a few months ago. If you don't want to wait for these conversations, head over to the Commercial Awareness Compass to get them straight to your inbox each week.

🚀 Boost your commercial awareness: https://www.allaboutlaw.co.uk/commercial-awareness-compass